Atrovent
Atrovent Price range: $ 22,00 through $ 65,00
Back to products
Aurogra
Aurogra Price range: $ 49,00 through $ 219,00

Augmentin

Price range: $ 56,00 through $ 678,00

Augmentin is a potent combination antibiotic designed to treat a wide variety of bacterial infections in adults and children. It contains amoxicillin and clavulanate potassium, a formula that works effectively to overcome bacterial resistance. This medication is commonly used to address infections of the lower respiratory tract, such as pneumonia and bronchitis. It is also highly effective against ear infections, sinusitis, and infections involving the skin or urinary tract. By eliminating harmful bacteria, Augmentin helps restore health and prevents the spread of infection throughout the body.

Active substance: amoxicillin, clavulanate
SKU: Augmentin Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Augmentin belongs to the class of combination penicillin-class antibacterial agents. The drug contains amoxicillin, a beta-lactam antibiotic, combined with clavulanate potassium, a beta-lactamase inhibitor, to expand its antibacterial spectrum against resistant organisms.

In the United States, Augmentin is classified as a prescription medication dispensable only pursuant to a valid order from a licensed healthcare provider in accordance with federal and state regulations.

Parameter Details
Active Ingredient (INN) Amoxicillin and Clavulanate Potassium
Therapeutic Class Aminopenicillin and Beta-Lactamase Inhibitor Combination
Dosage Forms Oral Tablets, Chewable Tablets, Powder for Oral Suspension
Route of Administration Oral
Prescription Status Prescription (Rx) Only
Storage Conditions Tablets: 20°C to 25°C (68°F to 77°F); Suspension: 2°C to 8°C (36°F to 46°F)

Clinical Profile and Pharmacological Action

What it’s used for

Augmentin is indicated for the treatment of infections caused by susceptible isolates of designated microorganisms in specific clinical conditions. FDA-approved indications include lower respiratory tract infections, such as community-acquired pneumonia caused by beta-lactamase-producing isolates of Haemophilus influenzae or Moraxella catarrhalis. It is also indicated for acute bacterial otitis media, acute bacterial sinusitis, skin and skin structure infections, and urinary tract infections. Responsible antibacterial usage requires that Augmentin be utilized solely to treat or prevent infections proven or strongly suspected to be caused by susceptible bacteria. The drug is clinically ineffective against viral pathogens, including influenza and the common cold. Off-label indications must be explicitly evaluated by a licensed prescriber based on microbiological data.

How the drug works

The mechanism of action of Augmentin relies on the dual activity of its active components. Amoxicillin exerts bactericidal action by binding to penicillin-binding proteins (PBPs), thereby inhibiting the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. This inhibition leads to osmotic lysis and cell death during active bacterial multiplication. Clavulanate potassium acts as a suicide inhibitor, irreversibly binding to and inactivating a wide range of beta-lactamase enzymes produced by Gram-negative and Gram-positive bacteria. By inactivating these enzymes, clavulanate protects amoxicillin from enzymatic degradation, thereby restoring and extending amoxicillin’s spectrum of activity against beta-lactamase-producing bacterial strains.

Dosing schedule

The dosing schedule of Augmentin varies according to the specific indication, infection severity, patient age, body weight, and renal function. Standard adult oral formulations include 500 mg/125 mg or 875 mg/125 mg tablets administered every 8 to 12 hours as directed by a prescriber. Pediatric dosing is calculated based on the amoxicillin component per kilogram of body weight per day. A critical pharmacokinetic consideration is that two 250 mg/125 mg Augmentin tablets are not bioequivalent to one 500 mg/125 mg tablet; both contain 125 mg of clavulanic acid, and substituting two 250 mg tablets doubles the clavulanate dose, increasing the risk of severe gastrointestinal adverse effects. Administration should occur at the start of a meal to optimize absorption and minimize gastrointestinal intolerance.

What happens in the body

Following oral administration, both amoxicillin and clavulanate potassium are rapidly and well absorbed from the gastrointestinal tract. Peak serum concentrations of both components are attained within 1 to 2 hours after oral intake. Concurrent administration of food enhances the systemic absorption of amoxicillin and minimizes potential gastrointestinal distress. Both agents diffuse readily into most body tissues and fluids, including middle ear fluid, sinus secretions, alveolar tissue, and peritoneal fluid, though penetration into the central nervous system is minimal unless meninges are inflamed. Amoxicillin exhibits an elimination half-life of approximately 1.3 hours, while clavulanic acid has an elimination half-life of approximately 1.0 hour. Both components are excreted primarily unchanged via renal clearance.

Compatibility with other medicines

Co-administration of Augmentin with other pharmaceutical agents requires careful monitoring due to potential pharmacokinetic and pharmacodynamic interactions. Probenecid decreases the renal tubular secretion of amoxicillin, resulting in elevated and prolonged serum concentrations of amoxicillin, whereas clavulanate elimination remains largely unaffected. Concurrent administration with oral anticoagulants, such as warfarin, may prolong prothrombin time and increase the International Normalized Ratio (INR), necessitating frequent monitoring of coagulation parameters. Concurrent use of allopurinol increases the incidence of erythematous skin rashes. Additionally, broad-spectrum oral antibacterial agents like Augmentin may reduce the efficacy of combined oral contraceptives by altering gut flora, potentially decreasing estrogen reabsorption.

Safety, Precautions, and Clinical Considerations

Adverse reactions

Adverse reactions associated with Augmentin therapy predominantly involve the gastrointestinal system and skin. The most frequently reported adverse events include diarrhea, nausea, vomiting, abdominal discomfort, and loose stools. These effects are primarily linked to the clavulanic acid component and are often mitigated by consuming the dose at the beginning of a meal. Dermatologic reactions such as urticaria, pruritus, and maculopapular eruptions occur in a subset of patients. Less common but significant adverse reactions include hepatic dysfunction, characterized by elevations in serum transaminases, bilirubin, and alkaline phosphatase, as well as cholestatic jaundice. Moniliasis and vaginitis resulting from fungal overgrowth may also develop during treatment.

Red flags

Patients and caregivers must remain vigilant for severe adverse events requiring immediate emergency medical evaluation. Anaphylaxis and severe hypersensitivity reactions manifest as angioedema of the face, lips, tongue, or throat, alongside acute dyspnea, bronchospasm, and hypotension. Severe Cutaneous Adverse Reactions (SCAR), such as Stevens-Johnson syndrome or toxic epidermal necrolysis, present with widespread skin blistering, mucosal erosions, and fever. Clostridioides difficile-associated diarrhea (CDAD) may present as severe, persistent watery diarrhea, abdominal cramping, and fever, occurring during therapy or up to several weeks post-treatment. Signs of severe hepatic injury, including icterus, dark urine, and severe right upper quadrant abdominal pain, warrant prompt medical evaluation.

What to avoid while taking it

Augmentin should be taken at the start of a meal to enhance amoxicillin absorption and reduce the frequency and severity of gastrointestinal side effects. High-fat meals do not impair absorption, but fasting increases the incidence of nausea and abdominal cramps. Alcohol consumption does not directly alter the antimicrobial efficacy or chemical degradation of amoxicillin or clavulanate potassium; however, ethanol ingestion can exacerbate gastrointestinal irritation and impose additional metabolic strain on the liver. Consequently, avoiding alcohol during antibacterial therapy is recommended to minimize cumulative hepatic and gastrointestinal distress.

Missed dose

If a dose of Augmentin is missed, it should be administered as soon as remembered, provided the time of the next scheduled dose is not imminent. If the next scheduled dose is near, the missed dose should be omitted, and the established dosing regimen resumed. Patients must not double the dose to make up for a missed administration, as doubling the dose significantly increases the concentration of clavulanic acid, substantially heightening the risk of severe nausea, vomiting, and diarrhea.

Important precautions

Prior to initiating therapy with Augmentin, a thorough inquiry concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other beta-lactam antibiotics is required. Augmentin is contraindicated in patients with a history of serious hypersensitivity reactions or a history of cholestatic jaundice or hepatic dysfunction associated with previous Augmentin use. Dosage adjustment is mandatory for patients with severe renal impairment (glomerular filtration rate under 30 mL/min). In patients with infectious mononucleosis, administration of amoxicillin is associated with a high incidence of generalized erythematous skin rash; thus, Augmentin should be avoided in these individuals. Prescribers must evaluate risk-benefit profiles in pregnant or lactating individuals, as amoxicillin is excreted in human milk.

Storage and expiration

Augmentin oral tablets and chewable tablets should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). Dry powder for oral suspension must be kept tightly closed in its original container at or below 25°C (77°F). Once reconstituted by a pharmacist, the liquid oral suspension must be stored under refrigeration between 2°C and 8°C (36°F and 46°F). Any unused portion of the reconstituted suspension must be safely discarded after 10 days.

Common questions

Why is Augmentin instructed to be taken at the start of a meal?

Taking Augmentin at the beginning of a meal optimizes the gastrointestinal absorption of clavulanate potassium and amoxicillin while simultaneously minimizing the incidence and severity of gastrointestinal adverse effects, such as nausea and abdominal distress.

Can Augmentin 250 mg/125 mg tablets be substituted with two 250 mg chewable tablets?

No. Substitutions cannot be made directly because different formulation strengths contain varying ratios of amoxicillin to clavulanic acid. Two 250 mg/125 mg tablets contain 250 mg of clavulanic acid, whereas a single 500 mg/125 mg tablet contains only 125 mg of clavulanic acid, which could lead to excessive clavulanate intake.

How long after completing treatment can antibiotic-associated diarrhea occur?

Antibiotic-associated diarrhea, specifically Clostridioides difficile-associated diarrhea, can occur during active treatment or up to two months after the final dose of Augmentin has been administered. Persistent watery diarrhea requires prompt medical evaluation.

Does Augmentin alter the effectiveness of oral contraceptive pills?

Broad-spectrum antibiotics like Augmentin may alter intestinal microflora, which can potentially decrease the enterohepatic circulation of estrogens and reduce the reliability of oral steroid contraceptives. Additional non-hormonal contraceptive barrier methods are often recommended during therapy.

How is Augmentin dosing adjusted for individuals with kidney impairment?

Patients with renal clearance impairment require dosage modification based on the degree of glomerular filtration rate (GFR) reduction. For patients with a GFR less than 30 mL/min, 875 mg tablet formulations are not recommended, and adjusted lower dosage strengths or extended dosing intervals are prescribed.

This text is for informational purposes only and does not constitute individual medical advice.

In accordance with FDA requirements.

Additional information
Dosage

250mg+125mg

,

500mg+125mg

,

875mg+125mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία

,